International Journal of Diabetes Mellitus
Volume 1, Issue 1 , Pages 55-56 , April 2009

A future hope for the treatment of diabetic retinopathy, manipulating hypoxia-inducible factor-1 alpha pathway

References 

  1. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 2001;280:C1358–C1366
  2. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245–248
  3. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Engl J Med. 1994;331:1480–1487
  4. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445–450
  5. Spranger J, Osterhoff M, Reimann M, et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes. 2001;50:2641–2645
  6. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450–1452
  7. Jiang BH, Semenza GL, Bauer C, et al. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol. 1996;271:C1172–C1180
  8. Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510–5514
  9. Huang LE, Gu J, Schau M, et al. Regulation of hypoxia-inducible factor 1 alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95:7987–7992
  10. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol. 2006;59:15–26
  11. Bunn HF, Gu J, Huang LE, et al. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J Exp Biol. 1998;201:1197–1201
  12. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604–4613
  13. Yamakawa M, Liu LX, Date T, et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res. 2003;93:664–673
  14. Abu El-Asrar AM, Missotten L, Geboes K. Expression of hypoxia-inducible factor-1 alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br J Ophthalmol. 2007;91:822–826
  15. Vincent KA, Shyu K-G, Luo Y, et al. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding on HIF-1 alpha/VP16 hybrid transcription factor. Circulation. 2000;102:2255–2261
  16. Matsuda T, Abe T, Wu JL, et al. Hypoxia-inducible factor-1 alpha DNA induced angiogenesis in a rat cerebral ischemia model. Neurol Res. 2005;27:503–508
  17. Giatromanolaki A, Sivridis E, Simopoulos C, et al. Hypoxia inducible factors 1 alpha and 2 alpha are associated with VEGF expression and angiogenesis in gall bladder carcinomas. J Surg Oncol. 2006;94:242–247
  18. Sivridis E, Giatromanolaki A, Gatter KC, et al. Tumor and Angiogenesis Research Group: Association of hypoxia-inducible factors 1 alpha and 2 alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer. 2002;95:1055–1063
  19. Kuwai T, Kitadai Y, Tanaka S, et al. Expression of hypoxia-inducible-1 alpha is associated with tumor vascularization in human colorectal carcinoma. In J Cancer. 2003;105:176–181
  20. Theodoropoulos VE, Lazaris ACH, Sofras F, et al. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol. 2004;46:200–208
  21. Jung F, Haendeler J, Hofmann J, et al. Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein Shc in endothelial cells. Circ Res. 2002;91:38–45
  22. Nilsson J, Shibuya M, Wennstrom S. Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp Cell Res. 2004;299:476–485
  23. Yu AY, Frid MG, Shimoda LA, et al. Temporal, Spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Lung Cell Mol Physiol. 1998;19:L818–L826
  24. Chavez JC, Almhanna K, Berti-Mattera LN. Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats. Neurosci Lett. 2005;374:179–182
  25. Jones DT, Harris AL. Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding. Mol Cancer Ther. 2006;5:2193

PII: S1877-5934(09)00006-X

doi: 10.1016/j.ijdm.2009.03.010

International Journal of Diabetes Mellitus
Volume 1, Issue 1 , Pages 55-56 , April 2009

Article Tools

* Image Usage & Resolution